[
    [
        {
            "time": "",
            "original_text": "[年报]健帆生物2019年净利润同比增长42% 拟10转9派9元",
            "features": {
                "keywords": [
                    "健帆生物",
                    "2019年",
                    "净利润",
                    "同比增长",
                    "42%",
                    "10转9派9元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[年报]健帆生物2019年净利润同比增长42% 拟10转9派9元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "健帆生物：2019年净利同比增42% 拟10转9派9元",
            "features": {
                "keywords": [
                    "健帆生物",
                    "2019年",
                    "净利",
                    "同比增",
                    "42%",
                    "10转9派9元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "健帆生物：2019年净利同比增42% 拟10转9派9元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "健帆生物(300529.SZ)拟斥1亿元设立全资子公司珠海健航",
            "features": {
                "keywords": [
                    "健帆生物",
                    "300529.SZ",
                    "1亿元",
                    "全资子公司",
                    "珠海健航"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "健帆生物(300529.SZ)拟斥1亿元设立全资子公司珠海健航",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "健帆生物：2019年净利同比42%，拟10转9派9元",
            "features": {
                "keywords": [
                    "健帆生物",
                    "2019年",
                    "净利",
                    "同比",
                    "42%",
                    "10转9派9元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "健帆生物：2019年净利同比42%，拟10转9派9元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【广证恒生医药】健帆生物（300529.SZ）-年度点评-灌流器持续渗透放量，2019年扣非业绩实现48%超高速增长",
            "features": {
                "keywords": [
                    "广证恒生医药",
                    "健帆生物",
                    "300529.SZ",
                    "年度点评",
                    "灌流器",
                    "持续渗透",
                    "放量",
                    "2019年",
                    "扣非业绩",
                    "48%",
                    "超高速增长"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【广证恒生医药】健帆生物（300529.SZ）-年度点评-灌流器持续渗透放量，2019年扣非业绩实现48%超高速增长",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]